132 related articles for article (PubMed ID: 14693064)
1. [Expression of P-glycoprotein and lung resistance protein in breast carcinoma and its relationship with prognosis].
Yu P; Xiao NX; Chen YP
Ai Zheng; 2003 Dec; 22(12):1339-42. PubMed ID: 14693064
[TBL] [Abstract][Full Text] [Related]
2. [The clinical significance of P-glycoprotein, lung resistance protein and multidrug resistance related protein expressions in infiltrating breast carcinoma tissues].
Zuo WS; Wei L; Song XR; Wang XW; Wang MY; Wang YS; Yu ZY; Bi Y
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3142-5. PubMed ID: 17313768
[TBL] [Abstract][Full Text] [Related]
3. Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy.
Rudas M; Filipits M; Taucher S; Stranzl T; Steger GG; Jakesz R; Pirker R; Pohl G
Breast Cancer Res Treat; 2003 Sep; 81(2):149-57. PubMed ID: 14572157
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of multidrug resistance proteins as a predictor of poor response to chemotherapy and prognosis in patients with nodal diffuse large B-cell lymphoma.
Ohsawa M; Ikura Y; Fukushima H; Shirai N; Sugama Y; Suekane T; Hirayama M; Hino M; Ueda M
Oncology; 2005; 68(4-6):422-31. PubMed ID: 16020972
[TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of P-gp/mdr1 mRNA, MRP and LRP in non-Hodgkin's lymphoma].
Li L; Su LP; Ma L; Zhao J; Zhu L; Zhou YA
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):199-202. PubMed ID: 19615260
[TBL] [Abstract][Full Text] [Related]
6. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications.
Berger W; Setinek U; Hollaus P; Zidek T; Steiner E; Elbling L; Cantonati H; Attems J; Gsur A; Micksche M
J Cancer Res Clin Oncol; 2005 Jun; 131(6):355-63. PubMed ID: 15856298
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma].
Yu DQ; Yi YF
Ai Zheng; 2003 May; 22(5):496-9. PubMed ID: 12753710
[TBL] [Abstract][Full Text] [Related]
9. [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma].
Katsaros D; Fracchioli S; Arts HJ; de Vries EG; Danese S; Richiardi G; Arisio R; Gordini G; Van der Zee AG; Suurmeijer AJ; Massobrio M
Minerva Ginecol; 1999 Dec; 51(12):463-70. PubMed ID: 10767994
[TBL] [Abstract][Full Text] [Related]
10. Expression of the lung resistance protein (LRP) in primary breast cancer.
Pohl G; Filipits M; Suchomel RW; Stranzl T; Depisch D; Pirker R
Anticancer Res; 1999; 19(6B):5051-5. PubMed ID: 10697509
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease.
Triller N; Korosec P; Kern I; Kosnik M; Debeljak A
Lung Cancer; 2006 Nov; 54(2):235-40. PubMed ID: 16934363
[TBL] [Abstract][Full Text] [Related]
13. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.
Arts HJ; Katsaros D; de Vries EG; Massobrio M; Genta F; Danese S; Arisio R; Scheper RJ; Kool M; Scheffer GL; Willemse PH; van der Zee AG; Suurmeijer AJ
Clin Cancer Res; 1999 Oct; 5(10):2798-805. PubMed ID: 10537344
[TBL] [Abstract][Full Text] [Related]
15. The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer.
Hu WQ; Peng CW; Li Y
J Exp Clin Cancer Res; 2009 Nov; 28(1):144. PubMed ID: 19930704
[TBL] [Abstract][Full Text] [Related]
16. Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.
Komdeur R; Plaat BE; van der Graaf WT; Hoekstra HJ; Hollema H; van den Berg E; Zwart N; Scheper RJ; Molenaar WM
Eur J Cancer; 2003 May; 39(7):909-16. PubMed ID: 12706359
[TBL] [Abstract][Full Text] [Related]
17. Expression of the lung resistance protein in primary colorectal carcinomas.
Pohl G; Suchomel RW; Stranzl T; Depisch D; Stiglbauer W; Filipits M; Pirker R
Anticancer Res; 2001; 21(1A):201-4. PubMed ID: 11299735
[TBL] [Abstract][Full Text] [Related]
18. Expression of multidrug resistance-related markers in primary neuroblastoma.
Lu QJ; Dong F; Zhang JH; Li XH; Ma Y; Jiang WG
Chin Med J (Engl); 2004 Sep; 117(9):1358-63. PubMed ID: 15377429
[TBL] [Abstract][Full Text] [Related]
19. [Study on the relationship among multidrug resistance factor expression of lung cancer tissues and clinicopathological characteristics in patients with lung cancer].
Zhang L; Yang H; Dong D
Zhongguo Fei Ai Za Zhi; 2006 Feb; 9(1):60-4. PubMed ID: 21144284
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of lung resistance-related protein in lower grade urothelial carcinoma of the renal pelvis and ureter.
Kong CZ; Zeng Y; Wu XX; Li JQ; Zhu YY; Chen Y
Int J Urol; 2004 Sep; 11(9):721-7. PubMed ID: 15379935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
